Clinical Trial Update: Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®

View source ↗

Summary

This clinical trial update describes the progression of a patient with severe late-onset Pompe disease and pulmonary dysfunction who is being treated with Myozy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Ii
• Pompe Disease

Drugs mentioned

• Myozyme (alglucosidase alfa)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pompe Disease (Late-Onset), Glycogen Storage Disease Type II (GSD II) | Status: COMPLETED